Applying implementation frameworks to the clinical trial context

被引:17
作者
Stensland, Kristian D. [1 ,2 ]
Sales, Anne E. [2 ,3 ,4 ,5 ]
Damschroder, Laura J. [3 ]
Skolarus, Ted A. [1 ,3 ]
机构
[1] Univ Michigan, Dept Urol, Dow Div Hlth Serv Res, NCRC Bldg 16,100S-12 2800 Plymouth Rd, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Learning Hlth Sci, Ann Arbor, MI 48109 USA
[3] VA Ann Arbor Healthcare Syst, Ctr Clin Management Res, Ann Arbor, MI USA
[4] Univ Missouri, Sinclair Sch Nursing, Columbia, MO USA
[5] Univ Missouri, Sch Med, Dept Family & Community Med, Columbia, MO USA
来源
IMPLEMENTATION SCIENCE COMMUNICATIONS | 2022年 / 3卷 / 01期
关键词
Implementation outcomes; Determinants; Implementation research logic model; Consolidated framework for implementation research; Implementation mapping; Clinical trials;
D O I
10.1186/s43058-022-00355-6
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundClinical trials advance science, benefit society, and provide optimal care to individuals with some conditions, such as cancer. However, clinical trials often fail to reach their endpoints, and low participant enrollment remains a critical problem with trial conduct. In these ways, clinical trials can be considered beneficial evidence-based practices suffering from poor implementation. Prior approaches to improving trials have had difficulties with reproducibility and limited impact, perhaps due to the lack of an underlying trial improvement framework. For these reasons, we propose adapting implementation science frameworks to the clinical trial context to improve the implementation of clinical trials.Main textWe adapted an outcomes framework (Proctor's Implementation Outcomes Framework) and a determinants framework (the Consolidated Framework for Implementation Research) to the trial context. We linked these frameworks to ERIC-based improvement strategies and present an inferential process model for identifying and selecting trial improvement strategies based on the Implementation Research Logic Model. We describe example applications of the framework components to the trial context and present a worked example of our model applied to a trial with poor enrollment. We then consider the implications of this approach on improving existing trials, the design of future trials, and assessing trial improvement interventions. Additionally, we consider the use of implementation science in the clinical trial context, and how clinical trials can be "test cases" for implementation research.ConclusionsClinical trials can be considered beneficial evidence-based interventions suffering from poor implementation. Adapting implementation science approaches to the clinical trial context can provide frameworks for contextual assessment, outcome measurement, targeted interventions, and a shared vocabulary for clinical trial improvement. Additionally, exploring implementation frameworks in the trial context can advance the science of implementation through both "test cases" and providing fertile ground for implementation intervention design and testing.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] The role of stakeholder mapping and engagement in Mongolia during the implementation of the STREAM clinical trial for MDR-TB
    Bazarragchaa Tsogt
    Meera Gurumurthy
    Elisa Giallongo
    Karen Sanders
    Ganzorig Munkhjargal
    Zayakhuu Khukhuukhen
    Enkhjin Bolormaa
    Enkhtuvshin Raash
    Naranbat Nyamdavaa
    Gay Bronson
    Trials, 26 (1)
  • [22] Investigating the Efficacy of Clinical Trial Monitoring Strategies: Design and Implementation of the Cluster Randomized START Monitoring Substudy
    Katherine Huppler Hullsiek
    Jonathan M. Kagan
    Nicole Engen
    Jesper Grarup
    Fleur Hudson
    Eileen T. Denning
    Catherine Carey
    David Courtney-Rodgers
    Elizabeth B. Finley
    Per O. Jansson
    Mary T. Pearson
    Dwight E. Peavy
    Waldo H. Belloso
    Therapeutic Innovation & Regulatory Science, 2015, 49 : 225 - 233
  • [23] Investigating the Efficacy of Clinical Trial Monitoring Strategies: Design and Implementation of the Cluster Randomized START Monitoring Substudy
    Hullsiek, Katherine Huppler
    Kagan, Jonathan M.
    Engen, Nicole
    Grarup, Jesper
    Hudson, Fleur
    Denning, Eileen T.
    Carey, Catherine
    Courtney-Rodgers, David
    Finley, Elizabeth B.
    Jansson, Per O.
    Pearson, Mary T.
    Peavy, Dwight E.
    Belloso, Waldo H.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2015, 49 (02) : 225 - 233
  • [24] Applying implementation science frameworks to identify factors that influence the intention of healthcare providers to offer PrEP care and advocate for PrEP in HIV clinics in Colombia: a cross-sectional study
    Martinez-Cajas, Jorge Luis
    Torres, Julian
    Mueses, Hector Fabio
    Plazas, Pilar Camargo
    Arrivillaga, Marcela
    Gomez, Sheila Andrea
    Galindo, Ximena
    Buitrago, Ernesto Martinez
    Llano, Beatriz Eugenia Alvarado
    IMPLEMENTATION SCIENCE COMMUNICATIONS, 2022, 3 (01):
  • [25] Comparing, Contrasting, and Integrating Dissemination and Implementation Outcomes Included in the RE-AIM and Implementation Outcomes Frameworks
    Reilly, Kathryn Louise
    Kennedy, Sarah
    Porter, Gwenndolyn
    Estabrooks, Paul
    FRONTIERS IN PUBLIC HEALTH, 2020, 8
  • [26] Understanding knowledge sharing in the work context by applying a belief elicitation study
    Stenius, Minna
    Hankonen, Nelli
    Haukkala, Ari
    Ravaja, Niklas
    JOURNAL OF KNOWLEDGE MANAGEMENT, 2015, 19 (03) : 497 - 513
  • [27] TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD): Design and implementation of randomized clinical trial
    Cross, Raymond K.
    Jambaulikar, Guruprasad
    Langenberg, Patricia
    Tracy, J. Kathleen
    Collins, Joseph F.
    Katz, Jonathan
    Regueiro, Miguel
    Schwartz, David A.
    Quinn, Charlene C.
    CONTEMPORARY CLINICAL TRIALS, 2015, 42 : 132 - 144
  • [28] Prototypical Clinical Trial Registry Based on Fast Healthcare Interoperability Resources (FHIR): Design and Implementation Study
    Gulden, Christian
    Blasini, Romina
    Nassirian, Azadeh
    Stein, Alexandra
    Altun, Fatma Betul
    Kirchner, Melanie
    Prokosch, Hans-Ulrich
    Boeker, Martin
    JMIR MEDICAL INFORMATICS, 2021, 9 (01)
  • [29] Interdisciplinary Priorities for Dissemination, Implementation, and Improvement Science: Frameworks, Mechanics, and Measures
    Brunner, Julian W.
    Sankare, Ibrahima C.
    Kahn, Katherine L.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2015, 8 (06): : 820 - 823
  • [30] Clinical trial variability: Quality control in a randomized clinical trial
    McGregor, Marion
    Cambron, Jerrilyn A.
    Jedlicka, James
    Gudavalli, M. Ram
    Contemporary Clinical Trials, 2009, 30 (01) : 20 - 23